Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,414,670
-
Number of holders
-
312
-
Total 13F shares, excl. options
-
27,985,360
-
Shares change
-
+597,864
-
Total reported value, excl. options
-
$4,594,004,259
-
Value change
-
+$104,275,194
-
Put/Call ratio
-
17%
-
Number of buys
-
136
-
Number of sells
-
-166
-
Price
-
$164.05
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q1 2021
356 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q1 2021.
Medpace Holdings, Inc. - Common Stock (MEDP) has 312 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27,985,360 shares
of 28,414,670 outstanding shares and own 98% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3,870,148 shares), VANGUARD GROUP INC (3,313,911 shares), WASATCH ADVISORS INC (2,653,986 shares), Invesco Ltd. (899,217 shares), STATE STREET CORP (829,322 shares), PRICE T ROWE ASSOCIATES INC /MD/ (756,852 shares), Pendal Group Limited (628,006 shares), DIMENSIONAL FUND ADVISORS LP (598,777 shares), Boston Trust Walden Corp (543,118 shares), and GEODE CAPITAL MANAGEMENT, LLC (496,459 shares).
This table shows the top 312 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.